...
首页> 外文期刊>Radiology >Costs and clinical outcomes after coronary multidetector CT angiography in patients without known coronary artery disease: comparison to myocardial perfusion SPECT.
【24h】

Costs and clinical outcomes after coronary multidetector CT angiography in patients without known coronary artery disease: comparison to myocardial perfusion SPECT.

机译:没有已知冠状动脉疾病的患者在进行冠状动脉多探测器CT血管造影后的费用和临床结局:与心肌灌注SPECT的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To assess costs and clinical outcomes in individuals without known coronary artery disease (CAD) who underwent multidetector computed tomographic (CT) angiography compared with those in matched patients who underwent myocardial perfusion single photon emission computed tomography (SPECT). MATERIALS AND METHODS: Data were captured from a deidentified, HIPAA-compliant data warehouse. We examined 1-year CAD costs (additional diagnostic coronary testing, CAD hospitalization, and coronary procedural and revascularization costs) and clinical outcomes in individuals without known CAD who underwent multidetector CT (n = 1647) compared with those in a matched cohort of patients who underwent myocardial perfusion SPECT (n = 6588). Cox proportional hazards models were employed for clinical outcome measures, including CAD hospitalization, myocardial infarction, and angina. RESULTS: Adjusted CAD costs in the multidetector CT group were 25.9% lower than in the myocardial perfusion SPECT group, by an averageof Dollars 1075 (95% confidence interval [CI]: Dollars 243, Dollars 2570) per patient. Those in the multidetector CT group were more likely to undergo downstream testing with myocardial perfusion SPECT (odds ratio, 6.65; 95% CI: 5.05, 8.75; P < .001), while those in the myocardial perfusion SPECT group were more likely to undergo downstream testing with invasive angiography (odds ratio, 6.25; 95% CI: 4.35, 9.09; P < .001). The multidetector CT group was less likely to undergo coronary revascularization (hazard ratio, 0.76; 95% CI: 0.75, 0.77; P < .001) than the myocardial perfusion SPECT group. There was no significant difference between multidetector CT and myocardial perfusion SPECT groups for rates of myocardial infarction (0.4% for both) or CAD hospitalization (0.7% vs 1.1%, respectively), while rates of angina were significantly lower in the multidetector CT group (4.3% vs 6.4%, P < .001). CONCLUSION: Individuals without known CAD who underwent multidetector CT as an initial diagnostic test, compared with those who underwent myocardial perfusion SPECT, incurred lower health care costs with similar rates of myocardial infarction and CAD-related hospitalization.
机译:目的:评估没有已知冠状动脉疾病(CAD)的个体与接受过心肌灌注单光子发射计算机断层扫描(SPECT)的匹配患者相比,进行多探测器计算机断层扫描(CT)血管造影的个体的成本和临床结果。材料和方法:数据是从一个不知名的,符合HIPAA要求的数据仓库中捕获的。我们比较了在没有已知CAD的情况下接受多探测器CT(n = 1647)且与之相匹配的同期队列患者相比,一年CAD费用(其他诊断冠状动脉测试,CAD住院以及冠脉手术和血运重建费用)和临床结局。进行了心肌灌注SPECT(n = 6588)。使用Cox比例风险模型进行临床结果测量,包括CAD住院,心肌梗塞和心绞痛。结果:多探测器CT组的调整后CAD费用比心肌灌注SPECT组低25.9%,平均每位患者1075美元(95%置信区间[CI]:243美元,2570美元)。多探测器CT组的患者更可能接受心肌灌注SPECT的下游检测(几率,6.65; 95%CI:5.05,8.75; P <.001),而心肌灌注SPECT组的患者更可能接受SPECT侵入性血管造影的下游测试(优势比,6.25; 95%CI:4.35,9.09; P <.001)。与心肌灌注SPECT组相比,多探测器CT组不太可能进行冠状动脉血运重建(危险比,0.76; 95%CI:0.75,0.77; P <.001)。在多层螺旋CT和心肌灌注SPECT组之间,心肌梗死发生率(两者均为0.4%)或CAD住院率(分别为0.7%和1.1%)无显着差异,而多层螺旋CT组的心绞痛发生率显着降低( 4.3%和6.4%,P <.001)。结论:与进行心肌灌注SPECT的患者相比,进行多探测器CT作为初始诊断测试的不知道CAD的患者在类似的心肌梗塞和与CAD相关的住院率下的医疗保健费用较低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号